The U.S. Pharmaceutical Isolators Market size is expected to reach USD 205.2 million by 2028, registering a CAGR of 5.8% from 2020 to 2028, according to a new report by Grand View Research, Inc. The rapid growth of the pharmaceutical industry in the U.S. and advancements in technologies used in the industry are anticipated to have a positive impact on market growth.
The growth of the industry in the U.S. is primarily
driven by continuous progress in the field of medicines and bioscience. The
rising demand for aseptically processed parenteral medicines, along with
increased investments in the industry, is anticipated to drive the market in
the U.S.
Pharmaceutical isolators are seeing fast-paced
technological advancements in aseptic processing in terms of incorporation of
robotics and automation solutions and industry 4.0. By integrating robotics
within gloveless pharmaceutical isolators, the risk of microbe contamination,
as well as particle contamination caused by human intervention is reduced.
The industry is moving toward energy efficiency and
sustainability. Pharmaceutical isolators offer higher energy efficiency as
compared to the Restricted Access Barrier System (RABS). Energy saving in pharmaceutical
isolators can be up to 65% as compared to 30% offered by RABS which is likely
to positively improve their demand.
Related Press Release@ U.S. Pharmaceutical Isolators Market Report
U.S. Pharmaceutical Isolators
Market Report Highlights
- The closed isolators segment is expected to witness a CAGR of 5.5%
from 2020 to 2028 owing to the ability to operate without personnel access
to the critical zone, making them suitable for application in the
preparation of toxic materials
- The positive pressure segment accounted for 53.9% of the overall
revenue share in 2020, owing to its demand in sterile processes when the
process is of particular significance and keeping any contaminants out of
the isolator is a priority
- Companies are collaborating with educational institutions along
with their in-house R&D facilities for developing processes and
technologies that offer a sustainable advantage in the future
- In February 2021, Comecer S.p.A partnered with Illuminate
Manufacturing Intelligence, to integrate Illuminate, a pharmaceutical
production solution based on industry 4.0, to get real-time updates of
their manufacturing equipment
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment